Synedgen to Partner with the NIH for Radiation Countermeasures Product…

Synedgen Active Agent SY303A will undergo Further Non-Clinical Efficacy Testing at the Armed Forces Radiobiology Research Institute (AFRRI), in Bethesda, Maryland

(PRWeb November 14, 2012)

Read the full story at http://www.prweb.com/releases/2012/11/prweb10130299.htm

Click here for reuse options!
Copyright 2012 Biotechblog

Comments are closed.

%d bloggers like this: